Pepta Labs
$32.99- Price / mg
- $3.30
- Document access
- On request
Free US shipping claimed
Three current public US 10 mg Semax listings compared with availability-aware list price, public evidence access, unit-cost normalization, shipping language, and dated source routes.
Current answer. As of Jul 23, 2026, 3 confirmed in-stock listings run from $32.99 to $50.00, with a $34.99 median across the in-stock rows. All 3 seller pages remain visible below.
Free US shipping claimed
Live UPS rate; free UPS 3 Day Select over $250
A list-price starting point, not a product-quality, safety, or seller recommendation.

List price, document access, and final landed cost answer different questions. This view keeps them separate instead of turning them into one seller score.
Free US shipping claimed
Open vendor evidence profile →Public batch reports. Access is public, but authenticity and custody are not established.
Inspect transparency record →This difference compares list prices only. It does not assign value to a report or include shipping.
Calculate landed cost →How to read it: Requiring a public document route changes the lowest visible list price from $32.99 to $34.99, a $2.00 difference before shipping. Document visibility is not product verification.
Filter Semax vendors by stock, price, and public documents →Rank rule. Price rank is availability-aware and stays fixed when you search or re-sort this view. Affiliate status never enters the calculation.
Compare two lowest in-stock rowsChecked July 28, 2026 at 4:47 PM UTC. Confirmed means the public source matched the published price and returned a reliable current availability signal. No row needs manual review. This does not verify vial contents or product quality.
Open source-check ledger| Price rank / supplier | 10 mg price | Price / mg | Public evidence | Shipping claim | Open listing |
|---|---|---|---|---|---|
01Pepta LabsLowest confirmed in-stock list priceIn stock | $32.99Source confirmed | $3.30 | COA on requestAccess: On request · Seller claim · Jul 23, 2026 | Free US shipping claimed | |
02Purgo LabsCurrent public batch reportsIn stock | $34.99Source confirmed | $3.50 | Public batch reportsAccess: Public link · Seller claim · Jul 23, 2026 | Live UPS rate; free UPS 3 Day Select over $250 | |
03Prime PeptidesPublic batch report linkedIn stock | $50.00Source confirmed | $5.00 | Report displayedAccess: Public link · Seller claim · Jul 23, 2026 | $9.95 US; free over $150 |
1 In-stock headline prices exclude unavailable listings, coupons, and checkout-only discounts.
2 A seller COA or report is labeled as a claim unless Peptide Local commissioned the sample and controlled custody.
How we read a certificate of analysis →How to verify the seller and access route →Start with how the document can be reached, then match it to this exact Semax 10 mg row. Access is useful evidence, but it does not prove authenticity, custody, vial contents, sterility, or suitability.
The exact 10 mg page was marked in stock and described independent HPLC purity and ESI-MS identity testing, with the batch certificate supplied on request rather than posted publicly.
The exact 10 mg page was marked in stock and linked current public batch reports, including a June 22, 2026 record. Peptide Local did not authenticate the custody trail or vial contents.
The 10 mg page displayed an ordering control and a third-party report route with batch, purity, date, laboratory, and verification key. Peptide Local did not commission the analysis.
The free checker keeps compound identity, lot matching, dates, laboratory attribution, report verification, custody, purity, identity testing, instrument output, and quantity separate.
These canonical matchups open directly on the Semax 10 mg board. Price, stock, document access, source freshness, and shipping stay separate.
Pepta Labs is $17.01 lower before shipping.
Pepta Labs is $2.00 lower before shipping.
Purgo Labs is $15.01 lower before shipping.
Pair selection prioritizes rows that are currently comparable, include the board low, or expose a meaningful document-access contrast. It is not a seller ranking.
The public list price moved from $29.99 in Peptide Local's 2026-07-17 snapshot to $32.99 after four matching source checks. That is a $3.00 increase, or 10.00%.
The listing was recorded as in stock at publication and displayed at price position 1 on the current exact-size board. Unavailable rows cannot set the current in-stock low. Price movement does not establish product identity, quality, safety, or market-wide inflation.
Open the complete Semax price history →Open the full peptide price change record →FDA lists Semax among bulk substances that may present significant safety risks in compounding and says important safety information is lacking for routes of administration in humans. Seller listings remain research-material claims.
Read the FDA source ↗Separate brain-imaging signals from proven nootropic benefit, then check human studies, side effects, and FDA status →PCAC recommended including both reviewed forms after reported 8-5-1 votes. The recommendation is nonbinding, does not approve a drug, and does not itself change the 503A Bulks List or validate any seller listing.
Open the compound evidence guide →Open the seven-substance FDA tracker →Price, chemical identity, clinical evidence, approved-product status, and local supply are different questions. This map shows which source answers each one and leaves unresolved fields visible.
Evidence routes checked through Jul 23, 2026This record resolves a name to the US laboratory research catalog tracked by Peptide Local. It does not establish authorization, lawful supply, medical use, or availability in the selected destination.
Read the FDA sourceU.S. Food and Drug Administration↗The price board can compare current list price, nominal size, availability, shipping language, and seller document access. It cannot establish identity, quantity, purity, sterility, legality, or fitness for use.
Inspect every price and source row3 currently confirmed in stock↓Semax is outside Peptide Local's current 13-program trial-count snapshot. That means no local count is published here, not that the count is zero. Search the live registry, then inspect the intervention, status, population, and posted results for each record.
Search Semax on ClinicalTrials.govLive official registry route, not a cached result count↗The global index joins this identity to official product and seller or supply routes in 22 content languages. Only 1 countries currently have a separate compound-specific status finding in this dataset.
Open the complete worldwide mapIdentity, product, seller, and supply checks stay separate↗A country finding applies only to the cited identity, destination, source date, and stated scope. It does not authenticate a different product or seller.
SAHPRA names Semax among peptide products unlawfully marketed in South Africa and states that products intended to treat, prevent, or alter bodily functions must be registered before sale. That guidance does not authenticate a specific online listing or seller.
It can show the visible list price, normalized unit cost, availability label, delivery claim, document language, destination market, and date checked.
A seller page or uploaded certificate does not replace independent sampling, chain-of-custody evidence, regulatory authorization, or professional judgment.
Current exact-size answers for price, document access, shipping, and source checks. No seller is converted into a product-quality or safety recommendation.
As of Jul 23, 2026, the lowest confirmed in-stock public list price in Peptide Local's exact-size US research-market sample is $32.99 from Pepta Labs. Shipping, tax, coupons, subscriptions, bundles, and checkout-only fees are not included.
2 confirmed in-stock rows link to a public seller document route: Purgo Labs, Prime Peptides. The lowest of those rows is Purgo Labs at $34.99. Public access does not authenticate a report, establish custody, or prove the contents of a supplied vial.
No. The board compares public single-unit list prices for the same 10 mg nominal size. The current lowest row states: Free US shipping claimed. Use the landed-cost calculator before treating the list-price order as the final order cost.
Confirm the exact identity and nominal size, current availability, landed cost, seller identity, destination-market rules, document route, lot or batch matching, analytical method, and source date. A seller-labelled research listing is not an approved medicine and public price or document access does not establish identity, purity, quantity, sterility, safety, legality, or fitness for human use.
Start by matching the exact Semax identity and 10 mg listing to a current lot or batch identifier. Then check analysis date, named laboratory, report verification route, sample custody, separate purity and identity methods, instrument output, and any measured quantity result. Peptide Local's free ten-field checker can organize those questions, but document completeness does not prove authenticity or the contents of a supplied vial.
These pair guides compare research-market identity, exact board size, seller overlap, price footprint, and evidence access. They do not rank effects or recommend personal use.
These guides explain local verification and access routes. They do not relabel this US research-price board as local inventory or medical availability.